Nanomedicine-based drug delivery strategies for the treatment of atherosclerosis
Atherosclerosis, a highly prevalent cardiovascular disease, has significantly contributed to morbidity and mortality worldwide. Despite the availability of various treatment options in clinical practice, complete reversal of the atherosclerotic pathological process remains challenging. Traditional a...
Saved in:
Main Authors: | Yongfang Lin (Author), Ruibo Lin (Author), Han-Bin Lin (Author), Shiyang Shen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Advances on targeted nanomedicines for atherosclerosis
by: Qinggong Han, et al.
Published: (2022) -
Nanomedicine-based disulfiram and metal ion co-delivery strategies for cancer treatment
by: Xinyue Shen, et al.
Published: (2024) -
Biomimetic nanomedicines for precise atherosclerosis theranostics
by: Ying Tao, et al.
Published: (2023) -
SMART Drug Based Targeted Delivery: A New Paradigm for Nanomedicine Strategies
by: Sugapriya Dhanasekaran
Published: (2015) -
Nanocolloids for Nanomedicine and Drug Delivery
by: Stefano Leporatti (Ed.)
Published: (2019)